{"id":"https://genegraph.clinicalgenome.org/r/f1e6e804-d8ce-4761-899e-e0d9bf2d8466v2.2","type":"EvidenceStrengthAssertion","dc:description":"Variants in *GRIN2D* were first reported in individuals with autosomal dominant global developmental delay and seizures in 2016 (Li et al., PMID: 27616483). Since then, many individuals have been reported with variants in *GRIN2D*, generally presenting with various seizure types, developmental delays, and muscle tone or movement abnormalities within the first year of life. Individuals frequently present with cerebral atrophy as well. For this reason, the Epilepsy GCEP has decided to curate variants in *GRIN2D* under the disease term complex neurodevelopmental disorder (MONDO:0100038).\n \nTwelve missense variants that have been reported in 16 probands in 6 publications (PMIDs: 27616483, 30280376, 31504254, 32860008, 33397303, 33482465) are included in this curation. The mechanism of pathogenicity appears to be both loss- and gain-of-function (PMIDs: 35228668, 27616483). This gene-disease relationship is also supported by experimental evidence including in vitro functional assays and protein interaction studies (PMIDs: 18779583, 31504254 35228668). Disease-causing variants may show decreased receptor surface expression, either enhanced or reduced sensitivity to agonists, and altered channel open probability. In summary, *GRIN2D* has a definitive relationship with autosomal dominant complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. \n\nThis gene-disease pair was originally evaluated by the Epilepsy Gene Curation Expert Panel on July 3, 2018. It was re-evaluated on March 15, 2022. As a result of this reevaluation, the classification changed from Limited to Definitive due to publication of additional patients. This curation also underwent an administrative update on January 4, 2023 in which the disease term was changed from developmental and epileptic encephalopathy to a broader term, complex neurodevelopmental disorder. No new evidence has been reviewed or added.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f1e6e804-d8ce-4761-899e-e0d9bf2d8466","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a52befb3-e9e0-46f1-9abf-8ead03151230","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a52befb3-e9e0-46f1-9abf-8ead03151230_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2023-01-04T20:06:06.815Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/a52befb3-e9e0-46f1-9abf-8ead03151230_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2022-03-15T19:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a52befb3-e9e0-46f1-9abf-8ead03151230_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23ec9143-0261-45ab-ba18-f6489cdeb34f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23ec9143-0261-45ab-ba18-f6489cdeb34f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","allele":{"id":"https://genegraph.clinicalgenome.org/r/9677f981-9830-41b0-b393-746683faa2ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.2008C>T (p.Leu670Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/813811"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/23ec9143-0261-45ab-ba18-f6489cdeb34f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression in HEK293 cells revealed significantly enhanced agonist potency, and/or increased channel open probability","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dfd2fa4a-1ad1-4d75-b533-4029bd197d64","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfd2fa4a-1ad1-4d75-b533-4029bd197d64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","allele":{"id":"https://genegraph.clinicalgenome.org/r/a23c848d-f469-4ad7-a72e-29759ce74f0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.1999G>A (p.Val667Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10590055"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/dfd2fa4a-1ad1-4d75-b533-4029bd197d64_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Gain-of-function: Increased agonist potency in the mutant receptors compared to the WT receptors when expressed in oocytes in PMID: 27616483","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f128508d-d347-46b3-a1a8-f85e277a7d3c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f128508d-d347-46b3-a1a8-f85e277a7d3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27616483","allele":{"id":"https://genegraph.clinicalgenome.org/r/a23c848d-f469-4ad7-a72e-29759ce74f0d"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f128508d-d347-46b3-a1a8-f85e277a7d3c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Gain-of-function: Increased agonist potency in the mutant receptors compared to the WT receptors when expressed in oocytes","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0f7b6e70-0ff3-436f-98cc-b4c037230272","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f7b6e70-0ff3-436f-98cc-b4c037230272_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","allele":{"id":"https://genegraph.clinicalgenome.org/r/c2dbbbdc-1c19-49a9-aa2a-05d6ca0a70dc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.3812C>T (p.Ser1271Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1325738"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0f7b6e70-0ff3-436f-98cc-b4c037230272_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression in HEK293 cells revealed mild increase of agonist potency, reduced sensitivity to endogenous protons, and decreased channel open probability","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f20d37ad-57f1-4f7c-bf47-c5f714500354","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f20d37ad-57f1-4f7c-bf47-c5f714500354_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","allele":{"id":"https://genegraph.clinicalgenome.org/r/676b167b-3a3a-461b-be71-692d37f4ed26","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.2033C>A (p.Ala678Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1325737"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f20d37ad-57f1-4f7c-bf47-c5f714500354_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression in HEK293 cells revealed significantly enhanced agonist potency, and/or increased channel open probability, decrease current amplitude, consistent with reduced surface expression, and significantly decreased cell viability of rat cultured cortical neurons","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/fe4bb40e-1c34-486c-a1b3-805eedda358c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe4bb40e-1c34-486c-a1b3-805eedda358c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27616483","allele":{"id":"https://genegraph.clinicalgenome.org/r/a23c848d-f469-4ad7-a72e-29759ce74f0d"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/fe4bb40e-1c34-486c-a1b3-805eedda358c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Gain-of-function: Increased agonist potency in the mutant receptors compared to the WT receptors when expressed in oocytes","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0762b590-7d4d-4182-b5f2-4981c47dc17f","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0762b590-7d4d-4182-b5f2-4981c47dc17f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33482465","allele":{"id":"https://genegraph.clinicalgenome.org/r/a23c848d-f469-4ad7-a72e-29759ce74f0d"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0762b590-7d4d-4182-b5f2-4981c47dc17f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Gain-of-function: Increased agonist potency in the mutant receptors compared to the WT receptors when expressed in oocytes in PMID: 27616483","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/791da6dc-14dc-46d5-a1b3-a5304deafd3a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/791da6dc-14dc-46d5-a1b3-a5304deafd3a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30280376","allele":{"id":"https://genegraph.clinicalgenome.org/r/ab6e7427-2e4a-4072-8acf-3573c8e04f7b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.2080A>C (p.Ser694Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/599389"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6edd0214-1fa6-4758-b7c7-42adf2256c5b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6edd0214-1fa6-4758-b7c7-42adf2256c5b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32860008","allele":{"id":"https://genegraph.clinicalgenome.org/r/9110a667-2c9b-413b-970e-561eec3f8999","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.1724C>T (p.Ser575Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/974877"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3cc3e261-bb26-460e-a241-24d2a5b2e932","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3cc3e261-bb26-460e-a241-24d2a5b2e932_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","allele":{"id":"https://genegraph.clinicalgenome.org/r/ae368686-a5c6-4a2b-9189-8006c0eacf08","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.3937C>T (p.Arg1313Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1325739"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/3cc3e261-bb26-460e-a241-24d2a5b2e932_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression in HEK293 cells revealed mild increase of agonist potency, reduced sensitivity to endogenous protons, and decreased channel open probability","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6e81757e-6dfb-4b5c-a916-5f08350ac38f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e81757e-6dfb-4b5c-a916-5f08350ac38f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30280376","allele":{"id":"https://genegraph.clinicalgenome.org/r/1eb96de9-0899-4043-8c55-42ad9360debb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.1345G>A (p.Asp449Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/599390"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d724feb2-6db7-4c13-ad4a-2eb58fe2aa64","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d724feb2-6db7-4c13-ad4a-2eb58fe2aa64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33397303","allele":{"id":"https://genegraph.clinicalgenome.org/r/3feddd20-99ee-4610-8787-e00284f0f375","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.2021C>A (p.Thr674Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406698301"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/836bd10e-4416-41d8-94f9-b0cadbd8a171","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/836bd10e-4416-41d8-94f9-b0cadbd8a171_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e1ced63-ee31-4ca5-a371-9d66424cbd63","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.1718C>T (p.Ser573Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406696983"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/836bd10e-4416-41d8-94f9-b0cadbd8a171_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression in HEK293 cells revealed mild increase of agonist potency, reduced sensitivity to endogenous protons, and decreased channel open probability","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/cc377bcc-1ee2-4c0b-8343-296a18cdddff","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc377bcc-1ee2-4c0b-8343-296a18cdddff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30280376","allele":{"id":"https://genegraph.clinicalgenome.org/r/e0188c1e-3490-4d4a-a48d-541af223a71b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.2043G>C (p.Met681Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/599388"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/31869ced-490c-4bf8-8d5b-854e53bf5f1f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31869ced-490c-4bf8-8d5b-854e53bf5f1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","allele":{"id":"https://genegraph.clinicalgenome.org/r/47fb732e-539d-4df4-b58e-b5ced9fbf92a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000836.4(GRIN2D):c.2023G>A (p.Ala675Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/985175"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/31869ced-490c-4bf8-8d5b-854e53bf5f1f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression in HEK293 cells revealed significantly decrease current amplitude, consistent with reduced surface expression and significantly enhanced agonist potency, and/or increased channel open probability","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/24908409-c385-47d7-8204-ecac719df77d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24908409-c385-47d7-8204-ecac719df77d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","allele":{"id":"https://genegraph.clinicalgenome.org/r/9677f981-9830-41b0-b393-746683faa2ae"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/24908409-c385-47d7-8204-ecac719df77d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression in HEK293 cells revealed significantly enhanced agonist potency, and/or increased channel open probability","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":9.7},{"id":"https://genegraph.clinicalgenome.org/r/a52befb3-e9e0-46f1-9abf-8ead03151230_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a52befb3-e9e0-46f1-9abf-8ead03151230_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a78e5d34-3765-4053-a296-4beb3ad0330f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/879db6ac-5d3f-44ef-a18c-55c15e9472c8","type":"Finding","dc:description":"Authors found that functional NMDA receptors require assembly of two GluN1 subunits together with either two GluN2 subunits or a combination of GluN2 and GluN3 subunits. GluN1 subunits are encoded by GRIN1, which is strongly associated with Developmental and epileptic encephalopathy. Experiment was specifically a single-molecule fluorescence colocalization method that \"focuses selectively on the plasma membrane and simultaneously determines the subunit composition of hundreds of individual protein complexes within an optical patch on a live cell.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18779583","rdfs:label":"Coexpression of NR3 Reduces NR1/NR2 Receptor Density","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a9fea9ac-aa8a-497d-8afb-e74f08215638","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ce7c6b8-3b0f-44c2-aea2-7ada66969f8e","type":"Finding","dc:description":"Functional NMDA receptors require assembly of two GluN1 subunits together with either two GluN2 subunits or a combination of GluN2 and GluN3 subunits. The GluN2 subunits are the glutamate-binding components and are interchangeable: GRIN2A, GRIN2B, GRIN2C, GRIN2D","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35228668","rdfs:label":"Gain- and loss-of-function LBD mutants are both associated","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8af0df7b-887d-4e9e-912b-7e610c3d3ace","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d19f7fe9-7d2d-4180-a417-c020b28cc139","type":"Finding","dc:description":"Lesca et al., 2013; Lemke et al., 2013; Carvill et al., 2013","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27616483","rdfs:label":"NMDA receptor","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a52befb3-e9e0-46f1-9abf-8ead03151230_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62a053de-61c3-4b8d-aa6e-da637374977d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81af3be8-0f9b-4f3e-bfa4-c521702d1547","type":"FunctionalAlteration","dc:description":"Functional analysis in vitro reveals that all six variants decreased receptor surface expression, and some confer significantly enhanced agonist potency, and/or increased channel open probability, while the others result in a mild increase of agonist potency, reduced sensitivity to endogenous protons, and decreased channel open probability.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31504254","rdfs:label":"Mutant GluN2D receptors change NMDAR properties"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/68c3cee4-d39c-4970-aba9-feac6986c021","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8622de3a-6319-4e8f-af1a-d26feaac0e59","type":"FunctionalAlteration","dc:description":"activation by lower concentrations of co-agonists, increased current of open channel, slower deactivation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27616483","rdfs:label":"pharmacological properties"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a52befb3-e9e0-46f1-9abf-8ead03151230_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb678b15-5a72-4dec-bee2-5b3bebaa01ff","type":"EvidenceLine","calculatedScore":1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ee09eee-a4d9-481a-b80d-43e9f4a47730","type":"Finding","dc:description":"Assay shows excitotoxic cell death triggered by excessive influx of calcium due to the gain-of-function mutation. Effect is reduced by adding memantine (NMDA antagonist).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27616483","rdfs:label":"transfected rat cortical neurons","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":5705,"specifiedBy":"GeneValidityCriteria8","strengthScore":11.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/aWagcaQN1Js","type":"GeneValidityProposition","disease":"obo:MONDO_0100038","gene":"hgnc:4588","modeOfInheritance":"obo:HP_0000006"},"version":"2.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a52befb3-e9e0-46f1-9abf-8ead03151230-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}